Care Access - Gilroy

Gilroy, California 95020

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer Disease, Crohn's Disease

Studies at this site

• A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) — Running, not enrolling
• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed